DEC 15, 2016 07:00 AM PST

Characterization and affinity maturation of TCRmimic scFvs identified using phage display

SPONSORED BY: Abcam, Abcam
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • MD-PhD candidate, Johns Hopkins School of Medicine
    Biography
      Jackie Douglass completed bachelors' degrees in Chemical-Biological Engineering and Economics and a master's degree in Chemical Engineering Practice at MIT. She is currently an MD-PhD candidate at Johns Hopkins School of Medicine and is doing her PhD thesis in the lab of Bert Vogelstein.

      Her thesis involves using phage display to identify TCRmimic scFvs (antibody fragments) recognizing mutant peptide-HLA complexes and translating these scFvs into therapeutic formats.

    Abstract:

    DATE: December 15, 2016
    TIME: 7:00am PT, 10:00am ET, 3:00pm London, 4:00pm CET

    Phage display is an increasingly popular, robust, and rapid method of antibody identification, particularly for antigens not amenable to antibody discovery using traditional hybridoma technology. 

    During this session, we will review:

    • Identification of scFv antibody fragments using phage display
    • Expression, affinity maturation, and characterization of scFvs 

    Register today to hear more about this exciting topic, and have your questions answered during a live Q&A session!

    Learning Objectives:

    • Learn about a potential strategy for targeting neo-antigens for cancer therapies
    • Learn one use of phage display technology for developing therapeutic agents against cancer

    Show Resources
    You May Also Like
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    SEP 20, 2018 09:00 AM PDT
    C.E. CREDITS
    SEP 20, 2018 09:00 AM PDT
     DATE: September 20 2018TIME: 09:00am PDT, 12:00pm EDT Harnessing the immune system has emerged as a powerful therapeutic strategy in oncology. However, the limited...
    OCT 19, 2017 08:00 AM PDT
    C.E. CREDITS
    OCT 19, 2017 08:00 AM PDT
    DATE: October 19, 2017TIME: 08:00am PDT, 11:00am EDT Recent FDA approval of the first Chimeric Antigen Receptor T cell (CAR-T) therapy offers cancer patients more promise than...
    Loading Comments...